Product Theater:
Cytokinetics

Reviewing the Evidence for the Treatment of oHCM

Patients with obstructive hypertrophic cardiomyopathy (oHCM) can feel limited by their symptoms and diminished functional capacity. This presentation will focus on the management of adult patients with symptomatic oHCM, including a discussion of the clinically meaningful benefits associated with a treatment option that addresses the underlying pathology of oHCM. Join Dr. Owens as they walk through evidence supporting the role of this treatment option, including clinical trial results, the safety profile, and how to help patients start and stay on therapy.

The session will demonstrate how to identify suitable candidates for therapy, and review how to integrate treatment into real-world clinical practice. The audience will have an opportunity to ask questions.